✦ LIBER ✦

Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults

✍ Scribed by Rosalyn J. Singleton; Jay C. Butler; Lisa R. Bulkow; Debby Hurlburt; Katherine L. O’Brien; William Doan; Alan J. Parkinson; Thomas W. Hennessy

Book ID: 116959464
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 236 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.11.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact and effectiveness of 23-valent pn

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

✍ Nick J. Andrews; Pauline A. Waight; Robert C. George; Mary P.E. Slack; Elizabeth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Immunogenicity of the 23-valent pneumoco

Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska native chronic alcoholics compared with nonalcoholic native and non-native controls

✍ Brian J. McMahon; Alan J. Parkinson; Lisa Bulkow; Michael Davidson; Karen Wainwr 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 757 KB

Combined schedule of 7-valent pneumococc

Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease

✍ Louis Vernacchio; Ellis J. Neufeld; Kristin MacDonald; Susan Kurth; Saya Murakam 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

The Immunogenicity of 7‐Valent Pneumococ

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

✍ Goldblatt, David; Southern, Jo; Andrews, Nick; Ashton, Lindsey; Burbidge, Polly; 📂 Article 📅 2009 🏛 University of Chicago Press 🌐 English ⚖ 309 KB

Invasive pneumococcal infections in chil

Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination

✍ Thomas V Adamkiewicz; Sharada Sarnaik; George R Buchanan; Rathi V Iyer; Scott T 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Effectiveness of 23-valent polysaccharid

Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998–2003

✍ Eyasu H. Teshale; Debra Hanson; Brendan Flannery; Christina Phares; Mitchell Wol 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 162 KB